相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Effects of Lowering Homocysteine Levels With B Vitamins on Cardiovascular Disease, Cancer, and Cause-Specific Mortality Meta-analysis of 8 Randomized Trials Involving 37 485 Individuals
Robert Clarke et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial
G. J. Hankey et al.
LANCET NEUROLOGY (2010)
The Genetics of Primary Haemorrhagic Stroke, Subarachnoid Haemorrhage and Ruptured Intracranial Aneurysms in Adults
George Peck et al.
PLOS ONE (2008)
Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary Hepatocellular Carcinoma (HCC) in a Chinese population
Li-Na Mu et al.
CANCER CAUSES & CONTROL (2007)
Efficacy of folic acid supplementation in stroke prevention: a meta-analysis
Xiaobin Wang et al.
LANCET (2007)
Homocysteine, 5,10-methylenetetrahydrofolate reductase 677C>T polymorphism, nutrient intake, and incident cardiovascular disease in 24968 initially healthy women
Robert Y. L. Zee et al.
CLINICAL CHEMISTRY (2007)
Functional inference of the methylenetetrahydrofolate reductase 677 C > T and 1298A > C polymorphisms from a large-scale epidemiological study
Arve Ulvik et al.
HUMAN GENETICS (2007)
Effect of folic acid supplementation on risk of cardiovascular diseases - A meta-analysis of randomized controlled trials
Lydia A. Bazzano et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Methylenetetrahydrofolate reductase gene polymorphisms are associated with ischemic and hemorrhagic stroke: Dual effect of MTHFR polymorphisms C677T and A1298C
Ali Sazci et al.
BRAIN RESEARCH BULLETIN (2006)
Acute stroke in relation to homocysteine and methylenetetrahydrofolate reductase gene polymorphisms
M Dikmen et al.
ACTA NEUROLOGICA SCANDINAVICA (2006)
Homocysteine lowering and cardiovascular events after acute myocardial infarction
KH Bonaa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Improvement in stroke mortality in Canada and the United States, 1990 to 2002
QH Yang et al.
CIRCULATION (2006)
Folate, vitamin B12, and risk of ischemic and hemorrhagic stroke -: A prospective, nested case-referent study of plasma concentrations and dietary intake
B Van Guelpen et al.
STROKE (2005)
Asymmetric dimethyl-L-arginine (ADMA):: A possible link between homocyst(e)ine and endothelial dysfunction
MC Stühlinger et al.
CURRENT DRUG METABOLISM (2005)
Methylenetetrahydrofolate reductase gene polymorphisms in patients with cerebral hemorrhage
X Fang et al.
NEUROLOGICAL RESEARCH (2005)
Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death - The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial
JF Toole et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Folic acid-based multivitamin therapy to prevent stroke - The jury is still out
GJ Hankey et al.
STROKE (2004)
Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism:: prospective and case-control studies from the Copenhagen City Heart Study
J Frederiksen et al.
BLOOD (2004)
Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese
H Iso et al.
CIRCULATION (2004)
Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke - A multicenter case-control study in China
ZH Li et al.
STROKE (2003)
Methylenetetrahydrofolate reductase (MTHFR) 677C>T and methionine synthase reductase (MTRR) 66A>G polymorphisms:: association with serum homocysteine and angiographic coronary artery disease in the era of flour products fortified with folic acid
SBA Emmanouil et al.
ATHEROSCLEROSIS (2003)
Homocysteine, renal function, and risk of cardiovascular disease
R Clarke et al.
KIDNEY INTERNATIONAL (2003)
Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease
D Tanne et al.
STROKE (2003)
Homocysteine and essential hypertension
R Rodrigo et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
High plasma homocysteine concentrations are associated with plasma concentrations of thrombomodulin in patients with type 2 diabetes and link diabetic nephropathy to macroangiopathy
K Okumura et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2003)
Age dependence of the influence of methylenetetrahydrofolate reductase genotype on plasma homocysteine level
LD Spotila et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
The events registration and survey procedures in the Northern Sweden MONICA Project
B Stegmayr et al.
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2003)
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis
DS Wald et al.
BMJ-BRITISH MEDICAL JOURNAL (2002)
Homocysteine and risk of ischemic heart disease and stroke -: A meta-analysis
R Clarke et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Total plasma homocysteine level and risk of cardiovascular disease -: A meta-analysis of prospective cohort studies
LE Bautista et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2002)